EcoDrugPlus

Ensembl ID : ENSOKIG00005029617
Gene Symbol: -
Cross references: -
161 Possible Orthologues:

Ensembl ID : ENSOKIG00005032997
Gene Symbol: -
Cross references: -
518 Possible Orthologues:

Ensembl ID : ENSOKIG00005033340
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Ensembl ID : ENSOKIG00005005268
Gene Symbol: -
Cross references: -
378 Possible Orthologues:

Ensembl ID : ENSOKIG00005005097
Gene Symbol: -
Cross references: -
303 Possible Orthologues:

Ensembl ID : ENSOKIG00005036239
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSOKIG00005036155
Gene Symbol: -
Cross references: -
125 Possible Orthologues:

Ensembl ID : ENSOKIG00005020804
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSOKIG00005020768
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSOKIG00005040170
Gene Symbol: -
Cross references: -
174 Possible Orthologues:

Ensembl ID : ENSOKIG00005037993
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSOKIG00005034464
Gene Symbol: -
Cross references: -
161 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).